O steoarthritis of the glenohumeral joint is a life-altering disease, the treatment for which was dramatically changed in the 1970s with the introduction of shoulder arthroplasty. Initially, humeral head replacement alone was introduced for the treatment of glenohumeral osteoarthritis. Good results were reported, with most patients experiencing pain relief and return of shoulder function 1 . Yet some patients had a slow recovery of strength and had continuing shoulder fatigability.
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Glenoid resurfacing was later introduced by Neer, who found that patients had superior pain relief and greater patient satisfaction compared with humeral head replacement alone 2 . Indications for humeral head replacement alone were questioned [3] [4] [5] [6] [7] [8] [9] [10] [11] . Studies showed that, in comparison with total shoulder replacement, humeral head replacement led to better outcomes in patients with severe rotator cuff disease, persistent instability, and lack of glenoid bone stock 12, 13 , in part due to the early loosening and failure of the glenoid component that occurred after total shoulder replacement 6, [14] [15] [16] [17] . Glenoid component failure has been a major concern in shoulder arthroplasty. Progressive radiolucent lines are commonly found on postoperative radiographs of patients who have undergone glenoid resurfacing; however, the mere presence of these radiolucent lines is not always indicative of glenoid component failure requiring revision 6, 8, 14, 16 . Torchia et al. 18 showed that glenoid loosening was associated with pain, yet Boyd et al. found no association with progressive glenoid loosening and pain 6 . The condition of the glenoid is one of many factors influencing the decision-making to resurface the glenoid during shoulder arthroplasty. Other critical factors include patient age, the condition and integrity of the rotator cuff, and the presence of inflammatory arthritis. There is no formula to determine which patients should receive a hemiarthroplasty and which should receive a total shoulder arthroplasty. These factors have to be counterbalanced with the concern that exists regarding the durability of shoulder hemiarthroplasty. Other alternatives that have been used to avoid prosthetic glenoid implantation include biologic resurfacing of the glenoid with interpositional graft (fascia lata, capsule, or Achilles tendon) 19 , arthroscopic glenoplasty 20 , and glenoid reaming (''ream and run'') 21 . There are risks associated with all of these, and, although limited short-term success has been reported, none has demonstrated long-term durability.
The radiographic appearance and clinical features of the glenoid are critical in determining whether humeral head replacement alone will be successful. We previously reported that patients with concentric glenoids had better outcomes than those with eccentric glenoids 22 . This finding suggested that eccentric glenoid wear may be a relative contraindication for isolated humeral head replacement. Later studies further validated these results, including the study by Iannotti and Norris, which showed that patients with eccentric glenoid wear had better results with total shoulder arthroplasty than they did with humeral head replacement 23 . The purpose of the current study was to report on the long-term outcomes of patients treated with hemiarthroplasty for glenohumeral osteoarthritis and to compare the results with those from our previous study, which had much shorter follow-up 22 . The hypothesis was that, irrespective of glenoid type, the outcomes of hemiarthroplasty would deteriorate over time and patients with eccentric glenoid wear would fare worse.
Materials and Methods

I
n this retrospective study, we reviewed the forty-two patients with glenohumeral osteoarthritis who had been treated with shoulder hemiarthroplasty at our institution between June 1990 and December 1994. In our previously reported series 22 , thirty (thirty-one shoulders) of those forty-two patients were available for midterm follow-up at 7.9 years. From this original cohort, twentyseven patients (twenty-eight shoulders) were available for the current follow-up at 17.2 years after the initial hemiarthroplasty. Five of the original patients had died, but three had undergone revision arthroplasty prior to death and were included in our follow-up data. One patient refused to participate in follow-up due to continued pain. We obtained informed consent from participating patients, and our institutional review board approved this study.
There were fifteen men and fifteen women. Nine patients (ten shoulders) were treated for primary osteoarthritis, including seven men (one received bilateral treatment) and two women. Twenty-one patients (twenty-one shoulders) were treated for secondary osteoarthritis, including eight men and thirteen women. Of the patients with secondary osteoarthritis, seven had osteoarthritis as a result of prior trauma, four had osteoarthritis caused by a prior glenohumeral instability repair (three Putti-Platt and one Magnuson-Stack), seven had osteonecrosis of the humeral head, and three developed chronic arthritis as a result of other reasons (e.g., neonatal septic arthritis).
All surgical procedures were done through a standard deltopectoral approach and with use of anterior and inferior capsular release to allow for stable external rotation after repair of the subscapularis tendon. There was no intraoperative evidence of posterior glenohumeral subluxation. Four subacromial decompressions were performed, and no rotator cuff tears were present. All patients received a Neer II prosthesis (3M, St. Paul, Minnesota), and all patients followed a standard rehabilitation program starting immediately after the operation.
The condition of the glenohumeral joint was evaluated preoperatively on axillary radiographs and then confirmed at the time of surgery for the type of glenoid wear. At the time of this study, advanced imaging studies such as computed tomography (CT) and/or magnetic resonance imaging (MRI) were not routinely ordered prior to performing shoulder arthroplasty. We now routinely perform preoperative CT on all shoulder arthroplasty patients to better assess the glenoid wear, as axillary radiographs can be misleading. Additional intraoperative factors were noted, such as presence of scarring causing contractures, the presence of humeral osteophytes, and the presence of intraarticular loose bodies. Although no patients had rotator cuff tears, fraying of the tendons was evaluated. The type of glenoid wear was categorized as either type I or type II, consistent with categories used in our initial study. Type-I glenoids had a concentric cartilage degeneration pattern that created a concentric osseous surface without flattening or significant bone loss. Type-II glenoids were no longer concentric as a result of uneven bone loss in addition to the cartilage surface loss 22 . At the time of follow-up examination, patients were evaluated with a variety of outcome tools, including the Short-Form 36 (SF-36), the EuroQol, the modified Neer score, the American Shoulder and Elbow Surgeons (ASES) data sheet, the Simple Shoulder Test, a visual analog scale (VAS) for pain, an assessment of subjective satisfaction, and a validated, patient self-assessment range-of-motion questionnaire 24 . (Please see the Appendix for a description of the modified Neer rating scale, the EuroQol, and the patient self-assessment range-of-motion questionnaire.) The range-of-motion questionnaire is a validated self-reporting tool that allows patients to accurately determine their range of motion. This had been proven to be highly effective and accurate. Regarding the Neer rating scale, excellent and good were included in the satisfactory group, and fair and poor were included in the unsatisfactory group. Subjective satisfaction was evaluated on a scale of very satisfied, satisfied, or dissatisfied.
Statistical Methods
While the purpose of our study was to report the long-term results after humeral hemiarthroplasty, we also analyzed the effect of glenoid wear pattern and surgical indication. One null hypothesis stated that there is no difference in long-term outcomes of shoulder hemiarthroplasty in patients with concentric and eccentric glenoid wear. The second null hypothesis was that patients with primary osteoarthritis have similar long-term outcomes after shoulder hemiarthroplasty as patients whose osteoarthritis is secondary to trauma. We performed Student t tests to determine the significance of the differences seen in each group. e164(2)
Source of Funding
There were no external sources of funding provided for this study.
Results
T he loss of patients between the short-term (i.e., twentynine months) follow-up of thirty-one shoulders and the long-term (i.e., 17.2 years) follow-up of twenty-eight shoulders did not produce differences in the patient demographics.
The average length of follow-up of these patients was 17.2 years (range, thirteen to twenty-one years). The average age of the patients at the time of initial hemiarthroplasty was 55.5 years (range, twenty-six to eighty-one years; standard deviation, 12.7). The average age at the time of the most recent follow-up of 17.2 years was 71.46 years (range, 42.69 to eighty-five years).
The pertinent demographic data is listed in Table I . The overall Neer scores showed 25% (seven of twentyeight) satisfactory results and 75% (twenty-one of twenty-eight) unsatisfactory results. Eight shoulders (29%) had undergone revision arthroplasty and were considered as having a poor outcome. In total, there were four (14%) excellent results, three (11%) good results, three (11%) fair results, and eighteen (64%) poor results. Of the twelve shoulders with type-I glenoid wear, five (42%) had satisfactory results and seven (58%) had unsatisfactory results. Of the sixteen shoulders with type-II glenoid wear, two (13%) had satisfactory results and fourteen (88%) had unsatisfactory results. The outcomes were considered satisfactory in four (44%) of the nine shoulders with primary osteoarthritis and three (16%) of the nineteen shoulders with secondary osteoarthritis. The results are summarized in Table II along with the published results from the 2.4-year follow-up and the unpublished results from the midrange 7.9-year follow-up.
While the overall results were poor, a comparison of the Neer scores according to glenoid wear type and osteoarthritis type showed significant differences. The average modified Neer score, Neer rating, and Neer satisfaction for type-I glenoids were significantly better than they were for type-II glenoids (p = 0.015, 0.001, and 0.045, respectively) (Table III) . Only the Neer score was significantly better for patients with primary osteoarthritis than it was for patients with secondary osteoarthritis (65.29 [range, forty-seven to seventy-eight] compared with 54.46 [range, forty to seventy-seven], respectively; p = 0.036) (Table III) .
Overall, shoulder motion was significantly improved from baseline. Both active forward elevation and external rotation with the arm in 90°of abduction improved significantly (104°t o 141.8°[range, 45°to 180°] and 20.7°to 61.0°[range, 30°to 90°], respectively; p < 0.05) from the time that the preoperative baseline measurements were made until the time of final follow-up. The average level of active internal rotation did not improve significantly. Shoulder motion was obtained at the latest follow-up with a validated self-assessment form that was not available at the time of the initial surgery. At the time of long-term follow-up, the overall pain scores remained low at 2.20 (range, 0 to 8). The shoulder motion and pain outcomes showed more improvement for patients with type-I glenoids than for patients with type-II glenoids. The average forward elevation, external rotation with the arm in 90°of abduction, 
and internal rotation were better for patients with type-I glenoids, but the difference was not significant. The average active internal rotation was to the 5th lumbar vertebra for both type-I and type-II glenoids. Pain scores were also very similar between the two groups (Table IV) . Shoulder motion outcomes with regard to forward elevation and external rotation with the arm in 90°of abduction were significantly better for patients with primary osteoarthritis than for patients with secondary osteoarthritis (p = 0.013 and 0.004, respectively) ( Table IV) . The long-term patient-centered outcome scores for the patients with nonrevised shoulders were compared with the preoperative and short-term scores of patients from the same cohort. The average ASES scores for the nonrevised shoulders at the time of long-term follow-up showed improvement over the short-term follow-up scores. The overall outcome scores for the twenty nonrevised shoulders at the time of long-term follow-up were as follows: ASES score, 70.54 (range, 36.67 to 91.67); SF-36 score, 69.65 (range, 30 to 98.33); EuroQol score, 0.549 (range, 0.113 to 0.841); and the Simple Shoulder Test score, 8.15 (range, 4 to 12). Although the outcome measures were greater for patients with type-I glenoids than for those with type-II glenoids, there was a significant difference only for the EuroQol score (p = 0.020).
Subjective patient satisfaction varied according to glenoid type, with type-I glenoids associated with an average rating of ''very satisfied'' and type-II glenoids associated with an average rating of ''satisfied'' (Table V) . Patients who had primary osteoarthritis also fared better with regard to outcome scores and patient satisfaction than did patients who had secondary osteoarthritis (Table V) .
The overall revision rate was 29% (eight of twenty-eight shoulders). Shoulders with a type-I glenoid were revised at a rate of 25% (three of twelve shoulders), and shoulders with a type-II glenoid were revised at a rate of 31% (five of sixteen shoulders) (Fig. 1) . Patients who underwent revision had an average age of 51.0 years (range, twenty-six to eighty-one years) at the time of the index procedure. The patients who did not undergo revision had an average age of 57.1 years (range, e164 (4) T 21, 2012 twenty-seven to sixty-three years) at the time of surgery. Seven patients (eight shoulders) underwent revision. Of these seven, one patient who had undergone bilateral hemiarthroplasties for the treatment of primary osteoarthritis underwent revision procedures and received a total shoulder replacement for the right shoulder at four years and for the left shoulder at twelve years. Arthroscopic debridement of the glenohumeral joint was performed in the right shoulder two years after the initial surgery, and the hemiarthroplasty implant was converted to a total shoulder prosthesis two years later. The indication for both revisions was a painful hemiarthroplasty. Another hemiarthroplasty patient who had undergone prior glenohumeral instability repair with a Putti-Platt procedure underwent revision to a total shoulder prosthesis three years after the hemiarthroplasty procedure. One patient who initially had humeral head osteonecrosis underwent revision to a total shoulder prosthesis ten years after the hemiarthroplasty. A patient who had instability after trauma underwent revision to a total shoulder replacement at two years and then underwent total shoulder revision arthroplasty eleven years after the hemiarthroplasty. One patient who initially had osteonecrosis underwent revision hemiarthroplasty for a superiorly subluxating humeral head at nine years after the hemiarthroplasty. Another patient had pain and underwent revision prior to his death six years after the initial hemiarthroplasty. The final patient underwent revision to a total shoulder arthroplasty seventeen years after the original hemiarthroplasty.
Discussion
T he controversy regarding choice of arthroplasty for the treatment of glenohumeral osteoarthritis continues. Longterm follow-up results of our original cohort of patients show deteriorating outcomes for shoulders that undergo humeral head replacement for the treatment of primary and secondary glenohumeral arthritis. Overall patient function decreased in all patients, regardless of glenoid type or presenting diagnosis. The Neer satisfaction score decreased from 74% at 2.4 years, to 61% at 7.9 years, and ultimately to 25% at 17.2 years of follow-up.
There have been several studies that have reported on the long-term results after humeral head replacement. Rispoli et al. followed forty-nine patients and fifty-one humeral head replacements with an average follow-up of 11.3 years 12 . They found a revision rate of 25%, which is consistent with our revision rate of 29%. Fifty-eight percent of patients in this study had a satisfactory or excellent result according to a modified Neer rating system. Wirth et al. followed forty-three patients at an average of 7.5 years after hemiarthroplasty 13 . All parameters measured were better at the two-year postoperative evaluation. However, only the Simple Shoulder Test showed a significant retained high value at two and seven years. This study confirms our findings that shoulder function improves in the first few years after hemiarthroplasty but then steadily declines with long-term follow-up. Survivorship of hemiarthroplasty implants over time.
There are many studies that report the superior midterm to long-term results of total shoulder arthroplasty compared with humeral head replacement for glenohumeral osteoarthritis 3, [6] [7] [8] [9] [10] 16, 25 . Edwards et al. reported on the largest series to date (601 total shoulder arthroplasties and eighty-nine humeral head replacements) and noted that total shoulder arthroplasty had significantly better results than humeral head replacement across all parameters 8 . Orfaly et al. followed patients with humeral head replacement and total shoulder arthroplasty for an average of 4.3 years 10 and found that while pain scores between the hemiarthroplasty and total shoulder arthroplasty groups were similar, total shoulder arthroplasty led to a greater preoperative to postoperative increase in ASES scores. Sperling et al. reported their results at an average of 16.8 years of follow-up after humeral head replacement and total shoulder arthroplasty 3 . Patients who had undergone humeral head replacement had 60% unsatisfactory results and a revision rate of 18% at ten years and 25% at twenty years. The revision rates following total shoulder arthroplasty were much lower, with 3% at ten years and 16% at twenty years.
Some authors have postulated that a benefit of humeral head replacement in young patients is that it allows for a simple conversion to total shoulder arthroplasty if that procedure becomes necessary in the future. One of our study patients exemplified how difficult conversion can be: first he underwent a humeral head replacement that failed; then he required a complex conversion to total shoulder arthroplasty, which also failed; and finally he underwent a re-revision total shoulder arthroplasty less than two years later. In addition to anecdotal evidence, several studies have shown the difficulty of predicting outcomes following revision conversion arthroplasty. Sperling and Cofield followed eighteen patients who had undergone conversion of humeral head replacement to total shoulder replacement 26 . At an average follow-up of 5.5 years, they demonstrated a reduction in pain and an improvement in function after conversion to total shoulder arthroplasty, but seven patients continued to have unsatisfactory results. In another study, Carroll et al. 7 also showed similar results. Sixteen consecutive patients underwent revision to total shoulder arthroplasty at an average of 3.5 years after initial humeral head replacement. At an average of 5.5 years of follow-up, 47% of patients had an unsatisfactory outcome. These two studies illustrate that conversion of a humeral hemiarthroplasty to total shoulder arthroplasty is not straightforward and can result in limited improvement.
After our initial study with an average of 2.4 years of follow-up 22 , other studies confirmed that patients with concentric glenoids have better outcomes than patients with eccentric glenoids after humeral head replacement. Iannotti and Norris investigated preoperative characteristics that predicted a better postoperative outcome in both humeral hemiarthroplasty and in total shoulder arthroplasty 23 . Their cohort included 128 patients, twenty-nine of whom had eccentric glenoids. When compared with patients with eccentric glenoids who had humeral head replacement, patients with eccentric glenoids who underwent total shoulder arthroplasty had better results with regard to pain, satisfaction, quality of life, and ASES scores. Hettrich et al. reported similar results in seventy-one shoulders in sixty-eight patients at an average follow-up of forty-nine months, showing that, for shoulders without glenoid erosion, patient outcomes as measured by SF-36 and the Simple Shoulder Test were better 17 . Hasan et al. examined preoperative characteristics that led to the failure of sixty-four hemiarthroplasties and seventy-four total shoulder arthroplasties 16 , finding that 42% of patients with failed hemiarthroplasties had substantial glenoid erosion. Our current study confirms these results with regard to decreased satisfaction in patients with eccentric glenoid wear.
The current study has several limitations. It is a retrospective cohort study and does not have control groups, randomization, or blinding. The small patient cohort is another limitation. We may have been able to detect more significant differences in patient outcome if we had started with a larger sample size. Lastly, because many of the patients had secondary osteoarthritis, the findings of this study cannot be compared with the findings of previous studies that evaluated only primary glenohumeral osteoarthritis or randomized clinical trials that compared humeral head replacement with total shoulder replacement. In addition, univariate analysis does not allow definitive interpretation of the relationship between glenoid morphology and the etiology of osteoarthritis as they are not independent variables.
Despite these limitations, the major strength of this study was the ability to longitudinally follow the original cohort for almost two decades. Our data is in accordance with the literature that questions the use of humeral head replacement as the index procedure of choice for the treatment of glenohumeral arthritis. In addition to our results, many studies have shown poor results in long-term follow-up of humeral head replacement. When comparing total shoulder arthroplasty with humeral head replacement, the results favor the long-term results for total shoulder replacement. Many authors have cited the ability of converting humeral head replacements to total shoulder replacement as an indication for hemiarthroplasty as first-line treatment for younger patients. However, the results of conversions are poor, and the long-term outcomes following total shoulder replacement are superior.
In summary, hemiarthroplasty for glenohumeral osteoarthritis is associated with poor durability and decreasing survivorship with long-term follow-up. Patients with concentric glenoid wear and patients with eccentric glenoid wear both demonstrated lower patient outcomes over time. However, patients with eccentric glenoids had even poorer results than those with concentric glenoids with longer-term follow-up. Based on our experience, we prefer total shoulder replacement to hemiarthroplasty for the surgical management of glenohumeral osteoarthritis in shoulders with an intact rotator cuff.
Appendix
A description of the modified Neer rating scale, the EuroQol, and the patient self-assessment range-of-motion questionnaire is available with the online version of this article as a data supplement at jbjs.org. n 
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